Institutional accumulation regime. Strong business quality combined with supportive market trend. Valuations remain demanding and supported by current metrics.
SENTINEL REVIEW
Anupam Rasayan India Limited (ANURAS)โขUpdated yesterday
๐จ Structural Deterioration Signature: In FY2026, Anupam Rasayan India Limited is experiencing severe operating deterioration, marked by a 76.6% YoY deterioration in reported net profit and persistent margin compression: EBIT margins fell to 8.8% from 17.4% YoY, signaling significant internal efficiency stress. Profitability is further strained by a 32.5% inventory-revenue divergence and a 68.3% receivables-revenue divergence, indicating slowing collections and channel demand pressures. This operating stress is reflected in a 37.6% drop in operating cash flow to โน334.3 Cr, compounded by operational friction: expenses outpacing sales, debtor days at 137.0, and a 37.7% YoY debt expansion to โน1,814.7 Cr. Against this liquidity strain, interest coverage narrowed to 2.42x, pushing the firm into Flagium's heightened surveillance range.
- โRisk score deteriorated (QoQ change: +19 pts)
- โProfitability margins pressure eased (Industrial Margin Stress resolved)
- โWorking Capital Expansion resolved this quarter (8.8 pts)
- โNew risk trigger: Receivables-Revenue Divergence (+13 pts)
- โGrowth expectations are demanding
- โMarket structure is declining (Stage 4)
- โInstitutional flow regime is Accumulation (0.81ฯ)
- โShare price is down -2.5% this quarter (from โน1,181 on 30 Sept to โน1,151.4)
- ๐ดReview 4 active forensic warning flags for structural stress
- ๐ขIndustrial Margin Stress resolved in latest filing; verify sustainability in next filing
- ๐ขMaintain routine quarterly surveillance; no governance escalation required
- 16.1 ptsBalance Sheet Stress
- 9.7 ptsEarnings Quality
- 8.0 ptsGrowth Sustainability
Divergence Radar
Structural Matrix
Risk vs Price TimelineVisualizing the historical relationship between the structural risk score and stock price movement over time.
| Duration | Perf. | Sector Avg | Divergence |
|---|---|---|---|
| 1 Week | +4.36% | -1.46% | +5.82% |
| 1 Month | -3.01% | -6.69% | +3.68% |
| 6 Months | -14.32% | +6.82% | -21.14% |
| 1 Year | +5.45% | +8.93% | -3.48% |
| 2 Year | +60.5% | +47.64% | +12.86% |
| 3 Year | +35.47% | +125.5% | -90.03% |
Business Analysis Methodology
Business analysis focuses on structural risk inside the company. Flagium monitors earnings quality, balance sheet strength, liquidity, governance, competitive position, and growth sustainability to identify areas where risk may be increasing or decreasing before it becomes obvious in reported results.
Financial profile remains stable for now. Weakness is detected in balance sheet stress. This suggests a building risk profile. Risk is increasing at a faster pace.
Risk Score Composition
Investment Risk Thesis
Current risk score has risen from 24 โ 34 over 12 quarters.
- Operating profit margins
- Inventory turnover
- Interest coverage ratio
Risk Drivers (Active Warnings)
Primary Driver & Insights
Working capital cycles are stretching, led by receivables-revenue divergence. This delays cash generation from core operations and locks up liquidity.
Active Risk Objects (13)Free Preview (2 of 13)
ANURAS: Trade Receivables growth outpaced Revenue by +68.3 pp (DSRI: 1.79x).
Early signs of slowing collections. Monitor for pressure on the cash flow cycle.
ANURAS: Inventory growth outpaced Revenue growth by +32.5 pp (Inventory holding ratio increased +37.6%).
Slight build-up in inventory detected. Monitor for slowing sales momentum.
Unlock All 13 Forensic Signals (11 Additional Warnings Gated)
Free accounts preview the top 2 highest-impact warning signals. Upgrade to Flagium Pro to inspect all 13 active forensic detectors, multi-quarter duration streaks, and financial stress metrics for Anupam Rasayan India Limited.
Statutory Note: Forensic signals are algorithmic quantitative observations derived from publicly filed XBRL disclosures and do not constitute allegations of legal misconduct or investment recommendations.
Unlock Interactive Signal Evidence Dossier
Access complete multi-quarter financial evidence, 5-KPI snapshot strips, diagnostic hypotheses, and 1-page forensic PDF dossiers for Anupam Rasayan India Limited.
Structural Risk Attribution
Deterministic quarter-on-quarter causal decomposition grounded in statutory exchange filings.
Structural History ยท Last 12 QuartersHistorical Trajectory (12Q)
Risk deteriorated materially (+19.0 pts), driven by new Receivables-Revenue Divergence (+13.0 pts) and new Universal Inventory Divergence (+9.1 pts), partially offset by Industrial Margin Stress relief (-14.8 pts) and Margin Compression relief (-10.1 pts).
12-Quarter Structural Regimes & Landmark Inflections12Q Structural Regimes & Inflections
Risk deteriorated materially (+16.0 pts), driven by new Inventory Stress (+18.0 pts) and new Capex Efficiency Stress (+10.8 pts), partially offset by Profit Collapse relief (-9.6 pts).
Business Resilience & Benchmark Context
Overall: HEALTHYPEER COMPARISON MATRIX
Ranked surveillance & credit risk comparison against sector peers
Stable
Stable
Stable
Stable
Watch
Watch
* Peer comparison is based on risk signals, not valuation or returns.
Unlock 5-Year Forensic Divergence Cockpit
Access multi-year visual divergence charts (EBITDA vs CFO Cash Gap, Receivables Decoupling Spread, and Debt vs FCF Burn) for Anupam Rasayan India Limited.
FINANCIAL STATEMENTS
Working Capital & Forensic Monitor
Operating Cycle Disclosuresยท8 Fiscal Years
Working Capital Schedule (INR Cr)
| Metric / Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
Trade Receivables(โน Cr) | 959 | 734 | 579 | 415 | โ | โ | โ | โ |
Inventories(โน Cr) | 1,775 | 1,452 | 1,055 | 931 | โ | โ | โ | โ |
Trade Payables(โน Cr) | 946 | 576 | 415 | 323 | โ | โ | โ | โ |
Net Working Capital(โน Cr) | 1,789 | 1,609 | 1,220 | 1,024 | โ | โ | โ | โ |
Working Capital / Sales(%) | 75.0% | 111.1% | 81.0% | 63.6% | โ | โ | โ | โ |
Cash Conversion & Operating Cycle (Days)
| Metric / Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
Cash Conversion Cycle (CCC)(days) | 274d | 406d | 295d | 232d | โ | โ | โ | โ |
Debtor Days (DSO)(days) | 147d | 185d | 140d | 94d | โ | โ | โ | โ |
Inventory Days (DIO)(days) | 272d | 366d | 256d | 211d | โ | โ | โ | โ |
Creditor Days (DPO)(days) | 145d | 145d | 101d | 73d | โ | โ | โ | โ |
Forensic Accounting Monitor & Divergences
| Metric / Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
Receivable Growth vs Sales (ฮ)(%) | -33.8% | +30.4% | +46.1% | โ | โ | โ | โ | โ |
Inventory Growth vs Sales (ฮ)(%) | -42.3% | +41.3% | +19.8% | โ | โ | โ | โ | โ |
Asset Growth vs Sales (ฮ)(%) | -12.5% | +18.3% | +28.3% | โ | โ | โ | +20.4% | โ |
Earnings-to-Cash Divergence (PAT - CFO)(โน Cr) | -112 | 190 | 108 | -75 | 323 | โ | -42 | 10 |
Accrual Ratio (Accruals / Avg Assets)(%) | -1.7% | 3.9% | 2.6% | -2.0% | โ | โ | -2.8% | 0.8% |
Operating Cash Realisation (CFO / EBITDA)(%) | 131.4% | -15.2% | 24.4% | 95.4% | -77.4% | โ | 70.4% | 41.9% |
Capitalisation Intensity (CWIP / Assets)(%) | โ | โ | โ | โ | โ | โ | โ | โ |
Industry Intelligence
Chemicals KPIs| Operating Driver | Quarter | Current Value | Change (QoQ) | Change (YoY) | Industry Median |
|---|---|---|---|---|---|
Gross Margin โ | Q1 FY2027 | 47.0% | +740 bps โ Operating efficiency gains | +2060 bps โ Operating efficiency gains | 48.5% |
| Q1 FY2027 | 26.2% | +420 bps โ Operating efficiency gains | -10 bps โ Profitability contraction | 15.5% |
Understanding Chemicals KPIs
Concall & Management Takeaways
No investor earnings call transcripts transcribed for this scrip.
Earnings call intelligence is automatically populated when companies conduct quarterly earnings calls with institutional investors and publish transcripts.
Business quality remains stable.
Current forensic pressure is elevated and stable.
Key risks remain concentrated in growth sustainability and operating leverage.
The risk profile is Early Signals and currently deteriorating. Recent structural triggers in balance sheet stress suggest a building pressure on the underlying framework. Material forensic traces are visible in core structural metrics, indicating a progressive erosion of structural stability. Strategic vigilance is advised as structural decay is accelerating.
Market Expectation Engine
Investor Translation โข What the market price is expecting
Expectation EngineAt the current price of โน1,151, the market expects this company to grow its revenue by 33.3% every year for the next 5 years. If you think the company will grow faster than 33.3%, current market prices reflect a discount relative to that growth assumption.
Sentinel Takeaway:The market expects future growth significantly above the company's historical delivery. Current market expectations appear demanding relative to the business's track record, resulting in higher expectation risk.
Using the Implied Revenue Model, the market is pricing ANURAS for 33.3% implied revenue growth versus 14.0% observed 3Y revenue CAGR. Current expectations appear demanding, and trailing fundamentals provide moderate support.
Business Delivery Capacity
Performance quality vs historical benchmarksHistorical business performance currently provides limited support for the market's implied growth assumptions. Improvement in revenue growth and operating efficiency would strengthen expectation support.
WHY IS EXPECTATION RISK ELEVATED?
Valuation Context
WHAT MUST HAPPEN FOR CURRENT PRICE TO BE CORRECT?
| Assumption Metric | Required (To justify current price) | Historical Delivery (Average) | Fulfillment Assessment |
|---|---|---|---|
| Revenue Growth (CAGR) | 33.3% | 14.0% | Aggressive |
| Operating Margin (EBIT) | 10.2% | 13.5% | Achievable |
| Free Cash Flow Conversion | -84.5% | -193.7% | Aggressive |
*Required metrics indicate the operating efficiency and revenue expansion parameters that must be sustained long-term to justify the current stock price.
The current valuation assumes business performance well above the company's historical record. Historical operating performance currently provides limited evidence that these expectations are sustainable. Continued stronger profitability and stronger cash generation would be required to justify current pricing.
Market Structure Methodology
Flagium separates Business Risk from Market Structure. Business analysis explains what is happening inside the company. Market Structure measures how investors are behaving through price trends, momentum, participation, and institutional activity. Divergences between the two often reveal important transitions before they become obvious.
The stock remains in a confirmed Stage 4 declining phase. Although institutional participation has improved, trend quality remains weak and momentum continues to deteriorate. Current price action does not yet confirm a structural recovery.
What Is Driving Market Structure?
Market structure shows partial alignment with the underlying fundamental risk profile.
Market Cycle Stage Analysis
Stan Weinstein 4-Stage CycleMomentum & Institutional Flow
Methodology & Regulatory Disclaimer
Flagium AI is an automated financial data analytics and research platform providing quantitative risk, forensic, and valuation analytics for informational and educational purposes only. Flagium AI is not registered with SEBI as a Research Analyst or Investment Adviser under SEBI regulations. These analytics do not constitute financial planning, investment advice, or recommendations to buy, sell, or hold any security.
Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered Investment Adviser before acting on any data presented.
๐ฌ Flagium Risk Brief โ Track forensic risks on ANURAS & 3 market anomalies weekly
See a sample issue โ